General Information of This Target (ID: PATR0CMGNI)
Target Name
Protein cereblon (CRBN)
Gene Name
CRBN
Gene ID
51185
Synonym
AD-006
Sequence
MAGEGDQQDAAHNMGNHLPLLPAESEEEDEMEVEDQDSKEAKKPNIINFDTSLPTSHTYL
GADMEEFHGRTLHDDDSCQVIPVLPQVMMILIPGQTLPLQLFHPQEVSMVRNLIQKDRTF
AVLAYSNVQEREAQFGTTAEIYAYREEQDFGIEIVKVKAIGRQRFKVLELRTQSDGIQQA
KVQILPECVLPSTMSAVQLESLNKCQIFPSKPVSREDQCSYKWWQKYQKRKFHCANLTSW
PRWLYSLYDAETLMDRIKKQLREWDENLKDDSLPSNPIDFSYRVAACLPIDDVLRIQLLK
IGSAIQRLRCELDIMNKCTSLCCKQCQETEITTKNEIFSLSLCGPMAAYVNPHGYVHETL
TVYKACNLNLIGRPSTEHSWFPGYAWTVAQCKICASHIGWKFTATKKDMSPQKFWGLTRS
ALLPTIPDTEDEISPDKVILCL

    Click to Show/Hide
Family
the CRBN family
Function
Substrate recognition component of a DCX (DDB1-CUL4-X-box) E3 protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteinssuch as MEIS2 or ILF2. Normal degradation of key regulatory proteins is required for normal limb outgrowth and expression of the fibroblast growth factor FGF8. Maintains presynaptic glutamate release and consequently cognitive functionssuch as memory and learningby negatively regulating large-conductance calcium-activated potassium (BK) channels in excitatory neurons. Likely to function by regulating the assembly and neuronal surface expression of BK channels via its interaction with KCNT1. May also be involved in regulating anxiety-like behaviors via a BK channel-independent mechanism. Plays a negative role in TLR4 signaling by interacting with TRAF6 and ECSITleading to inhibition of ECSIT ubiquitinationan important step of the signaling.

    Click to Show/Hide
Uniprot Entry
CRBN_HUMAN
HGNC ID
HGNC:30185
KEGG ID
hsa:51185
Full List of The ADC Related to This Target
Investigative
Click To Hide/Show 90 ADC Related to This Stage
ADC Name Antibody Antigen Payload Linker ADC Info
Rituximab-Compound (la) DAR 8 [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P1
Rituximab-Compound (la) linker
Pertuzumab-Compound(la) [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P1
Pertuzumab-Compound(la) linker
Trastuzumab-Compound (la) DAR 1.6 [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P1
Trastuzumab-Compound (la) DAR 1.6 linker
Trastuzumab-Compound (la) DAR 8 [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P1
Trastuzumab-Compound (la) DAR 8 linker
Pertuzumab-Compound (la) DAR 8 [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P1
Pertuzumab-Compound (la) DAR 8 linker
OR000213-Compound (Ia) [1]
OR000213
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
OR000213-Compound (Ia) linker
HuMy9-6IgG1-Compound (la) DAR 8 [1]
huMy9-6 IgG1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
huMy9-6IgG1-Compound (la) DAR 8 linker
Lintuzumab IgG1-Compound (la) DAR 8 [1]
Lintuzumab
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Lintuzumab IgG1-Compound (la) DAR 8 linker
OR000213-Compound(la) DAR 8 [1]
OR000213
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
OR000213-Compound(la) DAR 8 linker
HuMy9-6 IgG1-Compound (la) DAR 1.9 [1]
huMy9-6 IgG1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
huMy9-6 IgG1-Compound (la) DAR 1.9 linker
HuMy9-6IgG1-Compound (la) DAR3.9 [1]
huMy9-6 IgG1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
huMy9-6IgG1-Compound (la) DAR3.9 linker
HuMy9-6IgG1-Compound(la) DAR 5.5 [1]
huMy9-6 IgG1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
huMy9-6IgG1-Compound(la) DAR 5.5 linker
OR000213-Compound (la) DAR 1.2 [1]
OR000213
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
OR000213-Compound (la) DAR 1.2 linker
OR000213-Compound(la) DAR 1.8 [1]
OR000213
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
OR000213-Compound(la) DAR 1.8 linker
OR000213-Compound(la) DAR 2.3 [1]
OR000213
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
OR000213-Compound(la) DAR 2.3 linker
Trastuzumab-Compound (Ib) DAR1.5 [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P3
Trastuzumab-Compound (Ib) DAR1.5 linker
Trastuzumab-Compound (lc) [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P4
Trastuzumab-Compound (lc) linker
Rituximab-Compound (lc) [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P4
Rituximab-Compound (lc) linker
Pertuzumab-Compound(lc) [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P4
Pertuzumab-Compound(lc) linker
Trastuzumab-Compound (lc) DAR 8 [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P4
Trastuzumab-Compound (lc) DAR 8 linker
Pertuzumab-Compound (lc) DAR 8 [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P4
Pertuzumab-Compound (lc) DAR 8 linker
Trastuzumab-Compound (ld) DAR 1.6 [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P1
Trastuzumab-Compound (ld) DAR 1.6 linker
HuMy9-6IgG1-Compound (ld) DAR 8 [1]
huMy9-6 IgG1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
huMy9-6IgG1-Compound (ld) DAR 8 linker
Lintuzumab IgG1-Compound (ld) DAR 8 [1]
Lintuzumab
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Lintuzumab IgG1-Compound (ld) DAR 8 linker
Trastuzumab-Compound (le) [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P1
Trastuzumab-Compound (le) linker
Rituximab-Compound (le) [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P1
Rituximab-Compound (le) linker
Pertuzumab-Compound (le) [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P1
Pertuzumab-Compound (le) linker
Trastuzumab-Compound (lf) [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P6
Trastuzumab-Compound (lf) linker
Rituximab-Compound (lf) [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P6
Rituximab-Compound (lf) linker
Pertuzumab-Compound (lf) [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P6
Pertuzumab-Compound (lf) linker
Trastuzumab-Compound (lg) [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P2
Trastuzumab-Compound (lg) linker
Rituximab-Compound (lg) [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P2
Rituximab-Compound (lg) linker
Pertuzumab-Compound (lg) [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P2
Pertuzumab-Compound (lg) linker
Trastuzumab-Compound (lh) [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P13
Trastuzumab-Compound (lh) linker
Rituximab-Compound (lh) [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P13
Rituximab-Compound (lh) linker
Pertuzumab-Compound (lh) [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P13
Pertuzumab-Compound (lh) linker
Trastuzumab-Compound (li) [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P1
Trastuzumab-Compound (li) linker
Rituximab-Compound (li) [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P1
Rituximab-Compound (li) linker
Pertuzumab-Compound (li) [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P1
Pertuzumab-Compound (li) linker
Trastuzumab-Compound (lj) [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P1
Trastuzumab-Compound (lj) linker
Rituximab-Compound (lj) [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P1
Rituximab-Compound (lj) linker
Pertuzumab-Compound (lj) [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P1
Pertuzumab-Compound (lj) linker
Trastuzumab-Compound (lk) [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P14
Trastuzumab-Compound (lk) linker
Rituximab-Compound (lk) [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P14
Rituximab-Compound (lk) linker
Pertuzumab-Compound (lk) [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P14
Pertuzumab-Compound (lk) linker
Trastuzumab-Compound (ll) [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P14
Trastuzumab-Compound (ll) linker
Rituximab-Compound (ll) [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P14
Rituximab-Compound (ll) linker
Pertuzumab-Compound (ll) [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P14
Pertuzumab-Compound (ll) linker
Trastuzumab-Compound (lm) [1]
Trastuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P14
Trastuzumab-Compound (lm) linker
Rituximab-Compound (lm) [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P14
Rituximab-Compound (lm) linker
Pertuzumab-Compound (lm) [1]
Pertuzumab
Receptor tyrosine-protein kinase erbB-2 (HER2)
NeoDegrader P14
Pertuzumab-Compound (lm) linker
Rituximab-Compound (la) DAR 4 [1]
Rituximab
B-lymphocyte antigen CD20 (MS4A1)
NeoDegrader P1
Rituximab-Compound (la) linker
HuAT12/5-Compound (Ia) [1]
HuAT12/5
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)
NeoDegrader P1
HuAT12/5-Compound (Ia) linker
Isatuximab-Compound (Ia) [1]
Isatuximab
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)
NeoDegrader P1
Isatuximab-Compound (Ia) linker
Daratumumab-Compound (Ia) [1]
Daratumumab
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)
NeoDegrader P1
Daratumumab-Compound (Ia) linker
Indatuximab-Compound (Ia) [1]
Indatuximab
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)
NeoDegrader P1
Indatuximab-Compound (Ia) linker
Belantamab-Compound (Ia) [1]
Belantamab
Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)
NeoDegrader P1
Belantamab-Compound (Ia) linker
Sacituzumab-Compound (Ia) [1]
Sacituzumab
Tumor-associated calcium signal transducer 2 (TACSTD2)
NeoDegrader P1
Sacituzumab-Compound (Ia) linker
U3-1784-Compound (Ia) [1]
U3-1784
Fibroblast growth factor receptor 4 (FGFR4)
NeoDegrader P1
U3-1784-Compound (Ia) linker
Cetuximab-Comound (Ia) [1]
Cetuximab
Epidermal growth factor receptor (EGFR)
NeoDegrader P1
Cetuximab-Comound (Ia) linker
Olaratumab-Compound (Ia) [1]
Olaratumab
Platelet-derived growth factor receptor alpha (PDGFRA)
NeoDegrader P1
Olaratumab-Compound (Ia) linker
Ontuxizumab-Compound (Ia) [1]
Ontuxizumab
Endosialin (CD248)
NeoDegrader P1
Ontuxizumab-Compound (Ia) linker
Anti-CD33AB-Compound (Ia) [2]
Anti-CD33AB
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33AB-Compound (Ia) linker
Anti-CD33AB-Compound (Ib) [2]
Anti-CD33AB
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33AB-Compound (Ib) linker
Anti-CD33AB-Compound (Ic) [2]
Anti-CD33AB
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33AB-Compound (Ic) linker
Anti-CD33AB-Compound (Ie) [2]
Anti-CD33AB
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33AB-Compound (Ie) linker
Anti-CD33AB-Compound (Ih) [2]
Anti-CD33AB
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33AB-Compound (Ih) linker
Gemtuzumab-Compound (Ia) [2]
Gemtuzumab
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Gemtuzumab-Compound (Ia) linker
Gemtuzumab-Compound (Ib) [2]
Gemtuzumab
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Gemtuzumab-Compound (Ib) linker
Gemtuzumab-Compound (Ic) [2]
Gemtuzumab
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Gemtuzumab-Compound (Ic) linker
Gemtuzumab-Compound (Ie) [2]
Gemtuzumab
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Gemtuzumab-Compound (Ie) linker
Gemtuzumab-Compound (Ih) [2]
Gemtuzumab
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Gemtuzumab-Compound (Ih) linker
HuMy9-6-IgG4-S228P-Compound (Ia) [2]
huMy9-6-IgG4-S228P
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
huMy9-6-IgG4-S228P-Compound (Ia) linker
HuMy9-6-IgG4-S228P-Compound (Ib) [2]
huMy9-6-IgG4-S228P
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
huMy9-6-IgG4-S228P-Compound (Ib) linker
HuMy9-6-IgG4-S228P-Compound (Ic) [2]
huMy9-6-IgG4-S228P
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
huMy9-6-IgG4-S228P-Compound (Ic) linker
HuMy9-6-IgG4-S228P-Compound (Ie) [2]
huMy9-6-IgG4-S228P
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
huMy9-6-IgG4-S228P-Compound (Ie) linker
HuMy9-6-IgG4-S228P-Compound (Ih) [2]
huMy9-6-IgG4-S228P
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
huMy9-6-IgG4-S228P-Compound (Ih) linker
Anti-CD33 AB1 Compound (Ia) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33 AB1 Compound (Ia) linker
Anti-CD33 AB1 Compound (Ib) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33 AB1 Compound (Ib) linker
Anti-CD33 AB1 Compound (Ic) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33 AB1 Compound (Ic) linker
Anti-CD33 AB1 Compound (Id) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33 AB1 Compound (Id) linker
Anti-CD33 AB1 Compound (Ie) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33 AB1 Compound (Ie) linker
Anti-CD33 AB1 Compound (If) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P6
Anti-CD33 AB1 Compound (If) linker
Anti-CD33 AB1 Compound (Ig) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P2
Anti-CD33 AB1 Compound (Ig) linker
Anti-CD33 AB1 Compound (Ih) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33 AB1 Compound (Ih) linker
Anti-CD33 AB1 Compound (Ii) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33 AB1 Compound (Ii) linker
Anti-CD33 AB1 Compound (Ij) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P1
Anti-CD33 AB1 Compound (Ij) linker
Anti-CD33 AB1 Compound (Ik) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P14
Anti-CD33 AB1 Compound (Ik) linker
Anti-CD33 AB1 Compound (Il) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P14
Anti-CD33 AB1 Compound (Il) linker
Anti-CD33 AB1 Compound (Im) [3]
Anti-CD33 AB1
Myeloid cell surface antigen CD33 (CD33)
NeoDegrader P14
Anti-CD33 AB1 Compound (Im) linker
References
Ref 1 Neodegrader conjugates; 2021-10-07.
Ref 2 Neodegrader conjugates; 2021-10-07.
Ref 3 Neodegrader-anti-cd33 antibody conjugates; 2022-12-08.